Healthcare provider profile · identity verified

Kathleen E. Glaspy, M.D.

Internal Medicine · ORANGE, CA · NPI 1134311186

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	715	242
Amlodipine Besylate	Amlodipine Besylate	524	169
Losartan Potassium	Losartan Potassium	495	150
Levothyroxine Sodium	Levothyroxine Sodium	363	100
Hydrochlorothiazide	Hydrochlorothiazide	239	71
Lisinopril	Lisinopril	234	74
Simvastatin	Simvastatin	230	72
Alendronate Sodium	Alendronate Sodium	211	64
Metformin Hcl	Metformin Hcl	196	66
Omeprazole	Omeprazole	194	66
Tamsulosin Hcl	Tamsulosin Hcl	191	56
Trazodone Hcl	Trazodone Hcl	176	48
Rosuvastatin Calcium	Rosuvastatin Calcium	163	53
Atenolol	Atenolol	151	47
Gabapentin	Gabapentin	141	56
Alprazolam	Alprazolam	135	39
Pantoprazole Sodium	Pantoprazole Sodium	135	47
Famotidine	Famotidine	122	48
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	24
Metformin Hcl Er	Metformin Hcl	114	39
Metoprolol Succinate	Metoprolol Succinate	113	34
Ozempic	Semaglutide	108	21
Albuterol Sulfate Hfa	Albuterol Sulfate	106	39
Furosemide	Furosemide	101	33
Tramadol Hcl	Tramadol Hcl	100	24
Sertraline Hcl	Sertraline Hcl	99	34
Zolpidem Tartrate	Zolpidem Tartrate	99	23
Lovastatin	Lovastatin	83	23
Hydralazine Hcl	Hydralazine Hcl	82	27
Metoprolol Tartrate	Metoprolol Tartrate	82	28
Olmesartan Medoxomil	Olmesartan Medoxomil	79	22
Escitalopram Oxalate	Escitalopram Oxalate	78	30
Pravastatin Sodium	Pravastatin Sodium	77	25
Ezetimibe	Ezetimibe	76	26
Fluticasone Propionate	Fluticasone Propionate	76	36
Potassium Chloride	Potassium Chloride	76	27
Synthroid	Levothyroxine Sodium	72	19
Carvedilol	Carvedilol	69	24
Lorazepam	Lorazepam	66	21
Benazepril Hcl	Benazepril Hcl	60	17
Prednisone	Prednisone	60	36
Allopurinol	Allopurinol	59	18
Eliquis	Apixaban	58	25
Valsartan	Valsartan	58	21
Donepezil Hcl	Donepezil Hcl	54	20
Clopidogrel	Clopidogrel Bisulfate	53	15
Sumatriptan Succinate	Sumatriptan Succinate	53	19
Montelukast Sodium	Montelukast Sodium	52	18
Terazosin Hcl	Terazosin Hcl	52	12
Estradiol	Estradiol	51	23
Wixela Inhub	Fluticasone Propion/Salmeterol	51	19
Glipizide	Glipizide	47	17
Azithromycin	Azithromycin	46	42
Fluoxetine Hcl	Fluoxetine Hcl	43	16
Repatha Sureclick	Evolocumab	43	suppressed
Finasteride	Finasteride	39	14
Jardiance	Empagliflozin	39	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	13
Memantine Hcl	Memantine Hcl	39	suppressed
Spironolactone	Spironolactone	39	14
Ondansetron Hcl	Ondansetron Hcl	37	12
Azelastine Hcl	Azelastine Hcl	36	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	26
Diclofenac Sodium	Diclofenac Sodium	34	11
Meloxicam	Meloxicam	34	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	11
Triamcinolone Acetonide	Triamcinolone Acetonide	34	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	12
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Bupropion Xl	Bupropion Hcl	31	12
Buspirone Hcl	Buspirone Hcl	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Baclofen	Baclofen	28	11
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	27	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Naproxen	Naproxen	27	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Cephalexin	Cephalexin	25	20
Linzess	Linaclotide	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	20
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Duloxetine Hcl	Duloxetine Hcl	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	16
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Temazepam	Temazepam	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	17
Ketoconazole	Ketoconazole	20	11
Acyclovir	Acyclovir	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Lactulose	Lactulose	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Estradiol (Twice Weekly)	Estradiol	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Cefdinir	Cefdinir	13	suppressed
Clonidine	Clonidine	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Diazepam	Diazepam	13	suppressed
Donepezil Hcl Odt	Donepezil Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Mupirocin	Mupirocin	13	13
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Myrbetriq	Mirabegron	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error